Make your money go further for just 25p per day

PREMIUM

Overhyped perhaps - but don’t ignore AI!

03/07/2024 · Alphabet (GOOGL)  · Apple (AAPL)  · AstraZeneca (AZN)  · GSK (GSK)  · Novartis (NOVN)  · Nvidia (NVDA)  · Uber Technologies (UBER) 

UK US

Image in style of Monet illustrating AI

Is AI overhyped? Of course it is, but there are still plenty of opportunities for investors as we consider here, with three sectors set to be big winners. 


Remember to listen to Episode 24 of the Investor’s Champion Podcast

In this episode of the Investors Champion podcast, hosts Chris and Lee focus on the world of small caps and AIM. Topics include a discussion of YouGov’s profit warning, the contrasting fortunes of AIM’s cosmetics companies, a bizarre franchise creation and Supreme’s strange acquisition. Other companies covered include, Intercede, Chapel Down, Gear4Music, Time Finance, and PCI PAL. The episode also touches on notable market activities…

Continue reading our content…

Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
  • Unlimited access to our market-beating portfolios
  • In-depth coverage of many of the world’s great companies
  • Unique insights from our top research team
Register FREE for access to limited content.
  • Company and markets insights
  • Sponsored content
  • Podcasts

Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Alphabet

Episode 25 of the Investor’s Champion Podcast

06/07/2024 · Podcasts

In this episode of the Investors Champion Podcast, Chris and Lee start with a discussion on…


Overhyped perhaps - but don’t ignore AI!

03/07/2024 · Company Insights

Is AI overhyped? Of course it is, but there are still plenty of opportunities for investors…


More on Apple

Overhyped perhaps - but don’t ignore AI!

03/07/2024 · Company Insights

Is AI overhyped? Of course it is, but there are still plenty of opportunities for investors…


Episode 22 of the Investor’s Champion Podcast

15/06/2024 · Podcasts

In this episode of the Investors Champion podcast, hosts Chris and Lee delve into several key…


More on AstraZeneca

Overhyped perhaps - but don’t ignore AI!

03/07/2024 · Company Insights

Is AI overhyped? Of course it is, but there are still plenty of opportunities for investors…


AstraZeneca vs GlaxoSmithKline: a clear coronavirus winner?

31/07/2020 · Company Insights

The pharmaceutical industry has enjoyed a strong 2020. These are companies which – in the eyes…


More on GSK

Overhyped perhaps - but don’t ignore AI!

03/07/2024 · Company Insights

Is AI overhyped? Of course it is, but there are still plenty of opportunities for investors…


Mega-Trends Portfolio: CRISPR is the future

17/03/2021 · Portfolio

We have covered CRISPR/Cas9 before and hailed it as one of the most important inventions of…


More on Novartis

Overhyped perhaps - but don’t ignore AI!

03/07/2024 · Company Insights

Is AI overhyped? Of course it is, but there are still plenty of opportunities for investors…


Mega-Trends: A troubling 2021 opens opportunities for recovery

11/02/2022 · Portfolio

Sign-up to our free email updates

SIGN UP